CELSO
ARANGO LÓPEZ
Catedrático de universidad
Hospital Infantil Universitario Niño Jesus de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Infantil Universitario Niño Jesus de Madrid (45)
2022
-
Affective symptom dimensions in early-onset psychosis over time: a principal component factor analysis of the Young Mania Rating Scale and the Hamilton Depression Rating Scale
European Child and Adolescent Psychiatry, Vol. 31, Núm. 11, pp. 1715-1728
2021
-
Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 17
2018
-
Gray matter changes and cognitive predictors of 2-year follow-up abnormalities in early-onset first-episode psychosis
European Child and Adolescent Psychiatry, Vol. 27, Núm. 1, pp. 113-126
-
One-Year Prospective Study of Liver Function Tests in Children and Adolescents on Second-Generation Antipsychotics: Is There a Link with Metabolic Syndrome?
Journal of Child and Adolescent Psychopharmacology, Vol. 28, Núm. 7, pp. 463-473
2017
-
A developmental approach to dimensional expression of psychopathology in child and adolescent offspring of parents with bipolar disorder
European Child and Adolescent Psychiatry, Vol. 26, Núm. 10, pp. 1165-1175
2016
-
Absence of change in corrected QT interval in children and adolescents receiving antipsychotic treatment: A 12 month study
Journal of Child and Adolescent Psychopharmacology, Vol. 26, Núm. 5, pp. 449-457
2015
-
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis
European Child and Adolescent Psychiatry, Vol. 24, Núm. 12, pp. 1447-1459
-
Gender effects on brain changes in early-onset psychosis
European Child and Adolescent Psychiatry, Vol. 24, Núm. 10, pp. 1193-1205
-
Neurological adverse effects of antipsychotics in children and adolescents
Journal of Clinical Psychopharmacology, Vol. 35, Núm. 6, pp. 686-693
-
Predictors of functional and clinical outcome in early-onset first-episode psychosis: The child and adolescent first episode of psychosis (CAFEPS) study
Journal of Clinical Psychiatry, Vol. 76, Núm. 11, pp. e1441-e1448
-
Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model
European Child and Adolescent Psychiatry, Vol. 24, Núm. 4, pp. 427-440
-
The affective dimension of early-onset psychosis and its relationship with suicide
Journal of Child Psychology and Psychiatry and Allied Disciplines, Vol. 56, Núm. 7, pp. 747-755
2014
-
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis
Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 126-133
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
-
Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study
Schizophrenia Research, Vol. 152, Núm. 1, pp. 130-138
-
Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients
Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 53, Núm. 11, pp. 1179-1190.e4
2013
-
Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia
Schizophrenia Research, Vol. 143, Núm. 1, pp. 125-131
-
Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses
Psychological Medicine, Vol. 43, Núm. 4, pp. 757-768
-
Predictors of suicide attempt in early-onset, first-episode psychoses: A longitudinal 24-month follow-up study
Journal of Clinical Psychiatry, Vol. 74, Núm. 1, pp. 59-66
-
Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: Discontinuation and tolerability
Journal of Clinical Psychopharmacology, Vol. 33, Núm. 4, pp. 463-471